The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter

doi:10.1084/jem.172.6.1869

This Article

	Full Text (PDF, 704K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Granelli-Piperno, A.
	Articles by Steinman, R. M.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Granelli-Piperno, A.
	Articles by Steinman, R. M.


Social Bookmarking

	What's this?

ARTICLES

The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter

A Granelli-Piperno, P Nolan, K Inaba and RM Steinman
Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York, New York 10021.

Cyclosporin A (CSA), FK506, and glucocorticosteroids all inhibit the production of lymphokines by decreasing lymphokine gene expression. Previous experiments have defined six different sites that may contribute to the transcriptional control of the interleukin 2 (IL-2) promoter, and for each, active nuclear binding factors are induced upon mitogenic stimulation. While dexamethasone markedly blocks the increase in IL-2 mRNA in stimulated human blood T cells, we found that the drug does not block the appearance of factors that bind to the transcriptional control sites termed AP-1, AP-3, NF-kB, OCT-1, B site, and NF-AT. In contrast, both CSA and FK506 have similar effects: the drugs cause modest decreases in AP-3 and NF-kB, and markedly decreases in the activity of AP-1 and NF-AT. Therefore, CSA and FK506, while chemically different, seem to act upon a similar pathway that leads to IL-2 gene expression, whereas glucocorticoids do not affect this pathway.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Doller, A., Akool, E.-S., Muller, R., Gutwein, P., Kurowski, C., Pfeilschifter, J., Eberhardt, W. (2007). Molecular Mechanisms of Cyclosporin A Inhibition of the Cytokine-Induced Matrix Metalloproteinase-9 in Glomerular Mesangial Cells. J. Am. Soc. Nephrol. 18: 581-592 [Abstract] [Full Text]
Smith, L. (2003). Corticosteroids in Solid Organ Transplantation: Update and Review of the Literature. Journal of Pharmacy Practice 16: 380-387 [Abstract]
Barat, C., Tremblay, M. J. (2003). Treatment of Human T Cells with Bisperoxovanadium Phosphotyrosyl Phosphatase Inhibitors Leads to Activation of Cyclooxygenase-2 Gene. J. Biol. Chem. 278: 6992-7000 [Abstract] [Full Text]
Salvatori, L., Ravenna, L., Felli, M. P., Cardillo, M. R., Russo, M. A., Frati, L., Gulino, A., Petrangeli, E. (2000). Identification of an Estrogen-Mediated Deoxyribonucleic Acid-Binding Independent Transactivation Pathway on the Epidermal Growth Factor Receptor Gene Promoter. Endocrinology 141: 2266-2274 [Abstract] [Full Text]
Canettieri, G., Celi, F. S., Baccheschi, G., Salvatori, L., Andreoli, M., Centanni, M. (2000). Isolation of Human Type 2 Deiodinase Gene Promoter and Characterization of a Functional Cyclic Adenosine Monophosphate Response Element. Endocrinology 141: 1804-1813 [Abstract] [Full Text]
Tsuchida, M., Manthei, E. R., Alam, T., Knechtle, S. J., Hamawy, M. M. (1999). T Cell Activation Up-Regulates the Expression of the Focal Adhesion Kinase Pyk2: Opposing Roles for the Activation of Protein Kinase C and the Increase in Intracellular Ca2+. J. Immunol. 163: 6640-6650 [Abstract] [Full Text]
VELEZ, G., WHITCUP, S. M (1999). New developments in sustained release drug delivery for the treatment of intraocular disease. Br J Ophthalmol 83: 1225-1229 [Full Text]
Yoshida, T., Ishikawa, I., Ono, Y., Imai, T., Suzuki, R., Yoshie, O. (1999). An Activation-Responsive Element in Single C Motif-1/Lymphotactin Promoter Is a Site of Constitutive and Inducible DNA-Protein Interactions Involving Nuclear Factor of Activated T Cell. J. Immunol. 163: 3295-3303 [Abstract] [Full Text]
Hu, X. F., Slater, A., Kantharidis, P., Rischin, D., Juneja, S., Rossi, R., Lee, G., Parkin, J. D., Zalcberg, J. R. (1999). Altered Multidrug Resistance Phenotype Caused by Anthracycline Analogues and Cytosine Arabinoside in Myeloid Leukemia. Blood 93: 4086-4095 [Abstract] [Full Text]
Chow, C.-W., Rincon, M., Davis, R. J. (1999). Requirement for Transcription Factor NFAT in Interleukin-2 Expression. Mol. Cell. Biol. 19: 2300-2307 [Abstract] [Full Text]
Gualberto, A., Marquez, G., Carballo, M., Youngblood, G. L., Hunt, S. W. III, Baldwin, A. S., Sobrino, F. (1998). p53 Transactivation of the HIV-1 Long Terminal Repeat Is Blocked by PD 144795,�a Calcineurin-Inhibitor with Anti-HIV Properties. J. Biol. Chem. 273: 7088-7093 [Abstract] [Full Text]
Whitcup, S. M., Nussenblatt, R. B. (1997). Immunologic Mechanisms of Uveitis: New Targets for Immunomodulation. Arch Ophthalmol 115: 520-525 [Abstract]
Park, J., Yaseen, N. R., Hogan, P. G., Rao, A., Sharma, S. (1995). Phosphorylation of the Transcription Factor NFATp Inhibits Its DNA Binding Activity in Cyclosporin A-treated Human B and T Cells. J. Biol. Chem. 270: 20653-20659 [Abstract] [Full Text]
Heitman, J, Movva, N., Hall, M. (1991). Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253: 905-909 [Abstract]